[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100386031":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":17,"locations":27,"responsibleParty":106,"collaborators":7,"id":108,"slug":7,"hasResults":109,"nctId":110,"briefTitle":111,"officialTitle":111,"acronym":7,"eligibilityCriteria":112,"healthyVolunteers":113,"sex":114,"minAge":115,"maxAge":116,"enrollmentInfo":117,"targetDuration":7,"studyType":120,"phases":7,"briefSummary":121,"conditions":122,"keywords":126,"overallStatus":30,"whyStopped":7,"lastUpdateSubmitDate":132,"lastUpdatePostDateStruct":133,"startDateStruct":136,"completionDateStruct":138,"leadSponsor":140,"locationsCount":141},{"fullName":5,"class":6},"University of Aarhus","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Cognitive tests and Patient Reported Outcomes","Each patient will undergo cognitive tests and questionnaires",[13],{"name":14,"affiliation":15,"role":16},"Lene Haldbo-Classen, M.D","Aarhus University Hospital","PRINCIPAL_INVESTIGATOR",[18,23],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},"Morten Høyer, MD","CONTACT","+45 2328 2823","morthoey@rm.dk",{"name":24,"role":20,"phone":25,"phoneExt":7,"email":26},"Lene Haldbo-Classen, MD","+4523342761","lenhaldb@rm.dk",[28,46,65,76,91],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Department of Oncology, Rigshospitalet","RECRUITING","Copenhagen","Capital Region","2100","Denmark",{"type":36,"coordinates":37},"Point",[38,39],12.56553,55.67594,{"lat":39,"lon":38},[42],{"name":43,"role":20,"phone":44,"phoneExt":7,"email":45},"Aida Muhic","+45 35456942","aida.muhic@regionh.dk",{"facility":47,"status":30,"city":48,"state":49,"zip":50,"country":34,"cosmosGeoPoint":51,"geoPoint":55,"contacts":56},"Danish Center for Particel Therapy","Aarhus","Region Midt","8200",{"type":36,"coordinates":52},[53,54],10.21076,56.15674,{"lat":54,"lon":53},[57,60,63],{"name":58,"role":20,"phone":59,"phoneExt":7,"email":22},"Morten Høyer","+452328 2823",{"name":61,"role":20,"phone":62,"phoneExt":25,"email":26},"Lene Haldbo-Classen","+45 2334 2761",{"name":64,"role":16,"phone":7,"phoneExt":7,"email":7},"Petra Witt",{"facility":66,"status":30,"city":48,"state":49,"zip":50,"country":34,"cosmosGeoPoint":67,"geoPoint":69,"contacts":70},"Department of Oncology, Aarhus University Hospital",{"type":36,"coordinates":68},[53,54],{"lat":54,"lon":53},[71,75],{"name":72,"role":20,"phone":73,"phoneExt":7,"email":74},"Slavka Lucakova","+45 3027 2470","slvkluka@rm.dk",{"name":61,"role":16,"phone":7,"phoneExt":7,"email":7},{"facility":77,"status":30,"city":78,"state":79,"zip":80,"country":34,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Department of Oncology, Aalborg University Hospital","Aalborg","Region Nord","9000",{"type":36,"coordinates":82},[83,84],9.9187,57.048,{"lat":84,"lon":83},[87],{"name":88,"role":20,"phone":89,"phoneExt":7,"email":90},"Charlotte Haslund","+45 97661414","cah@rn.dk",{"facility":92,"status":30,"city":93,"state":94,"zip":95,"country":34,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Department of Oncology, Odense University Hospital","Odense","Region Syd","5000",{"type":36,"coordinates":97},[98,99],10.38831,55.39594,{"lat":99,"lon":98},[102],{"name":103,"role":20,"phone":104,"phoneExt":7,"email":105},"Rikke Dahlrot","+45 26242142","rikke.dahlrot@rsyd.dk",{"type":107,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100386031",false,"NCT04306432","Cognitive Function After Radiation Therapy for Primary Brain Tumours","Inclusion Criteria:\n\n* 18 years or older and Danish speaking.\n* Performance status WHO 0-2\n* Capable of cooperating on testing\n* Tumour histology (WHO 2016 classification) of the following types: anaplastic astrocytoma (IDH mutant), diffuse astrocytoma (IDH-mutant), gemistocytic astrocytoma (IDH mutant), diffuse astrocytoma (NOS), oligodendroglioma, meningioma, medulloblastoma (NOS), pituitary adenoma, other brain tumours including skull base sarcomas\n\nExclusion Criteria:\n\n* Glioblastoma\n* Performance status 3-4 (Karnofsky Performances of 60 or less)",true,"ALL","18 Years","100 Years",{"count":118,"type":119},300,"ESTIMATED","OBSERVATIONAL","This study will assess cognitive function in patients with a primary brain tumour treated with radiation therapy (RT) to generate radio-sensitivity and volume effect parameters for the development of cognitive dysfunction. All types of brain tumours apart from glioblastoma will be included.",[123,124,125],"Primary Brain Tumour","Radiation Toxicity","Cognitive Impairment",[127,128,129,130,131],"Brain tumour","Radiation therapy","Cognitive function","Hippocampus","Patient reported outcomes","2021-11-19",{"date":134,"type":135},"2021-12-02","ACTUAL",{"date":137,"type":135},"2019-01-03",{"date":139,"type":119},"2034-03-31",{"name":5,"class":6},5]